AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology…
Microland has been recognized as a Leader in the ISG Provider Lens 2024 for Multi Public Cloud Services in the U.S.
BENGALURU, India, Dec. 20, 2024 /PRNewswire/ -- Microland, a global digital transformation…
Miles Education Hosts India’s First-Ever Public Accounting GCC Conclave (M-PACT), Cementing India’s Role as a Global Accounting Powerhouse
BENGALURU, India, Dec. 20, 2024 /PRNewswire/ -- Miles Education, the flagbearer of…
CCTV+: 2024 Beijing Forum on Swift Response to Public Complaints opens in Beijing
BEIJING, Dec. 19, 2024 /PRNewswire/ -- The 2024 Beijing Forum on Swift…
Reviva Announces Proposed Public Offering
December 16, 2024 17:18 ET | Source: Reviva Pharmaceuticals CUPERTINO, Calif., Dec.…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…